Pulsed Radiofrequency in Postherpetic Neuralgia: Predictors of Treatment Response from a Doubly Robust Propensity-Weighted Real-World Study

Abstract Background Postherpetic neuralgia (PHN) is a debilitating complication of herpes zoster. Evidence supporting pulsed radiofrequency (PRF) in established chronic PHN remains limited, with inadequate adjustment for baseline confounders. We evaluated the association between PRF and treatment success and identified predictors of treatment response. Methods In this retrospective cohort study, 982 patients with PHN (pain persisting ≥ 12 weeks after rash onset) were analyzed. Patients who underwent PRF (n = 504)—targeting the dorsal root ganglion, the Gasserian ganglion, or involved peripheral nerves—were compared with controls who did not undergo PRF at any time during the study period and who received standard pharmacological and non-PRF interventional management (n = 478). Propensity score-based overlap weighting (ATO) balanced 29 baseline covariates. The primary outcome was treatment success at 12 weeks (≥ 2-point reduction on the 11-point numeric rating scale (NRS)). Effects were estimated using doubly robust estimation. Results After ATO adjustment, all covariates achieved adequate balance (standardized mean differences < 0.1). Treatment success at 12 weeks was 63.0% (PRF) versus 52.1% (control; doubly robust OR, 1.59; 95% CI, 1.12–2.25; P = .009). Greater mean pain reduction was observed at 4 weeks (P = .040) but not sustained thereafter. Exploratory subgroup analyses suggested PRF was more effective in patients with dysesthesia, without allodynia, and not receiving pregabalin or tramadol. Conclusions PRF provides clinically meaningful, albeit time-limited, pain reduction in PHN patients. Exploratory findings suggest that treatment response may vary according to sensory phenotype and pharmacological profile, underscoring the importance of profile-guided patient selection.

Authors

Institutions

Publication Details

Journal
Pain Medicine
Published
2026-11-14
DOI
https://doi.org/10.1093/pm/pnag116
Primary Topic
Pain Management and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pulsed Radiofrequency in Postherpetic Neuralgia: Predictors of Treatment Response from a Doubly Robust Propensity-Weighted Real-World Study

Hangaram Kim, Seungcheol Yu, 남승표, 박범일 et al.
Pain Medicine
Pain Management and Treatment
article

Pulsed Radiofrequency in Postherpetic Neuralgia: Predictors of Treatment Response from a Doubly Robust Propensity-Weighted Real-World Study

Hangaram Kim, Seungcheol Yu, 남승표, 박범일, Yongjae Yoo, Jee Youn Moon, Eun Bi Park, Kaehong Lee, Jeongsoo Kim
article en

Abstract

Abstract Background Postherpetic neuralgia (PHN) is a debilitating complication of herpes zoster. Evidence supporting pulsed radiofrequency (PRF) in established chronic PHN remains limited, with inadequate adjustment for baseline confounders. We evaluated the association between PRF and treatment success and identified predictors of treatment response. Methods In this retrospective cohort study, 982 patients with PHN (pain persisting ≥ 12 weeks after rash onset) were analyzed. Patients who underwent PRF (n = 504)—targeting the dorsal root ganglion, the Gasserian ganglion, or involved peripheral nerves—were compared with controls who did not undergo PRF at any time during the study period and who received standard pharmacological and non-PRF interventional management (n = 478). Propensity score-based overlap weighting (ATO) balanced 29 baseline covariates. The primary outcome was treatment success at 12 weeks (≥ 2-point reduction on the 11-point numeric rating scale (NRS)). Effects were estimated using doubly robust estimation. Results After ATO adjustment, all covariates achieved adequate balance (standardized mean differences < 0.1). Treatment success at 12 weeks was 63.0% (PRF) versus 52.1% (control; doubly robust OR, 1.59; 95% CI, 1.12–2.25; P = .009). Greater mean pain reduction was observed at 4 weeks (P = .040) but not sustained thereafter. Exploratory subgroup analyses suggested PRF was more effective in patients with dysesthesia, without allodynia, and not receiving pregabalin or tramadol. Conclusions PRF provides clinically meaningful, albeit time-limited, pain reduction in PHN patients. Exploratory findings suggest that treatment response may vary according to sensory phenotype and pharmacological profile, underscoring the importance of profile-guided patient selection.

Pain Medicine
New Generation University College (ET), Seoul National University Hospital (KR), SNUH SMG-SNU Boramae Medical Center (KR)
Pain Management and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon